Concepedia

Rifat Pamukcu

RP

Statistics

Publications

35

Citations

4K

H-Index

28

Active since

1984

Affiliations

Pathways Behavioral Services(Current)

Columbia University

Pathways

Columbia University Irving Medical Center

University of Colorado Denver

Rifat Pamukcu is an author at Pathways Behavioral Services specializing in pharmacology, oncology, and medicine.

Publications per year

1984–2018

35

Publications

35

Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.

Gary A. Piazza, Alanna L. Kulchak Rahm, Mary F. Krutzsch et al. · PubMed · 1995 · 434 citations

, , +15

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels.

Gary A. Piazza, David S. Alberts, Lee J. Hixson et al. · PubMed · 1997 · 361 citations

, , +15

Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.

Gary A. Piazza, A K Rahm, T S Finn et al. · PubMed · 1997 · 354 citations

, , +15

Exisulind induction of apoptosis involves guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin.

William J. Thompson, Gary A. Piazza, Han Li et al. · PubMed · 2000 · 305 citations

, , +16

Rapid development of colitis in NSAID-treated IL-10–deficient mice

Daniel Berg, Juan Zhang, Joel V. Weinstock et al. · Gastroenterology · 2002 · 277 citations · Full text

, , +14

1–5 of 35